2013, Number 4
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2013; 29 (4)
Adipose tissue as an alternative source for regenerative medicine
Socarrás-Ferrer BB, del Valle-Pérez LO, de la Cuétara-Bernal K, Galván-Cabrera JA, Bencomo-Hernández A, Macías-Abraham C
Language: Spanish
References: 30
Page:
PDF size: 0. Kb.
ABSTRACT
Adipose tissue is an alternative source in cell therapy due to various factors such as its easy extraction, its high content of mesenchymal stem cells and their capacity of
ex vivo expansion which can be equivalent or even superior to cells obtained from bone marrow in terms of its ability of differentiation potential of angiogenesis and its immunomodulatory effects in inflammation. These cells have the following expression profile: positive staining for CD29, CD44, CD54, CD90, CD105 and HLA-I; and negative for CD45, CD116, CD14, CD31 and HLA-II. At present, there is evidence that the stem cells derived from adipose tissue has have the potential to differentiate in addition to cells of mesodermal origin as neurons, pancreatic cells, endocrine, hepatocytes, cardiomyocytes and epithelial cells, among others. Because of All these factors and the absence of ethical and immunological problems suggest a new possibility in the treatment of many diseases common to everyday medical practice.
REFERENCES
Minteer D, Marra KG, Rubin JP. Adipose-derived mesenchymal stem cells: biology and potential applications. Adv Biochem Eng Biotechnol 2013;129:59-71. doi: 10.1007/10_2012_146. PMID: 22825719
Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012; 2012:812693. PMID: 22577397
Madriz de Haan P. Células madre: Fuentes no embriónicas accesibles. Med. Leg. Costa Rica [revista en la Internet]. 2010 Sep [citado 2012 Oct 02] ; 27(2): 35-46. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152010000200005&lng=es .
De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003 Oct 31;89(2-3):267-70. PMID:14556988
Meruane M, Rojas M. Células troncales derivadas del tejido adiposo. Int. J. Morphol. [revista en la Internet]. 2010 Sep [citado 2012 Oct 02] ; 28(3): 879-889. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022010000300035&lng=es. doi: 10.4067/S0717-95022010000300035.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. PMID: 16923606
Rada T, Santos TC, Marques AP, Correlo VM, Frias AM, Castro AG, Gomes ME, et al. Osteogenic differentiation of two distinct subpopulations of human adipose-derived stem cells: an in vitro and in vivo study. J Tissue Eng Regen Med. 2012 Jan;6(1):1-11. doi: 10.1002/term.388. PMID:21294275.
Rada T, Reis RL, Gomes ME. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 2009 Jun;15(2):113-25. PMID: 19196117.
Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med. 2011 May 10;9:52. PMID: 21569277.
Trounson A. New perspectives in human stem cell therapeutic research. BMC Med. 2009 Jun 11;7 :29. PMID: 19519878.
Mizuno H. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Curr Opin Mol Ther. 2010 Aug;12(4):442-9. PubMed; PMID: 20677095.
Kebriaei P, Robinson S. Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy. 2011 Mar;13(3):262-8. PMID: 21231805.
Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods. 2008 Jun;45(2):115-20. PMID: 18593609.
Estrada R, Venegas P. Comparación de diferentes protocolos para el cultivo de células madre mesenquimales de origen adiposo. Rev. Costarric. Cienc. Méd [revista en la Internet]. 2007 Jun [citado 2012 Oct 02] ; 28(1-2): 21-28. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0253-29482007000100003&lng=es.
Gruber HE, Somayaji S, Riley F, Hoelscher GL, Norton HJ, Ingram J, et al. Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence. Biotech Histochem. 2012 May;87(4):303-11. PMID:22250760
Van Harmelen V, Röhrig K, Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism. 2004 May; 53(5):632-7. PMID: 15131769.
Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M, Helder MN, Klein-Nulend J, Schouten TE, et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8(2):166-77. PMID: 16698690.
Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol. 2006 Jul;208(1):64-76. PMID:16557516.
Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005 Mar;23(3):412-23. PMID: 15749936.
Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006 Feb;24(2):376-85. PMID: 16322640
Matsumoto S. Islet cell transplantation for Type 1 diabetes. J Diabetes. 2010 Mar;2(1):16-22. doi: 10.1111/j.1753-0407.2009.00048.x PMID: 20923470.
Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest. 2010 Jan;120(1):11-9. doi: 10.1172/JCI40373. PMID: 20051632.
Dhawan A, Strom SC, Sokal E, Fox IJ. Human hepatocyte transplantation. Methods Mol Biol. 2010; 640:525-34. doi: 10.1007/978-1-60761-688-7_29. PMID: 20645072.
Kung JW, Forbes SJ. Stem cells and liver repair. Curr Opin Biotechnol. 2009 Oct; 20(5):568-74. PMID: 19837579
Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch. 2009 Apr;76(2):56-66. PMID:19443990
Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009 Jan;52(1):79-86. PMID: 19273960
Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells. 2007 Apr;25(4):818-27. PMID: 17420225
Rigotti G, Marchi A, Galiè M, Baroni G, Benati D, Krampera M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007 Apr 15;119(5):1409-22; discussion 1423-4. PMID: 17415234
Matsumoto D, Sato K, Gonda K, Takaki Y, Shigeura T, Sato T, et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006 Dec;12(12):3375-82. PMID:17518674
Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008 Jan;32(1):48-55; discussion 56-7. PMID: 17763894.